Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Every day without data lends credence to your story.
Dr. M said AVXL's particular expertise is in conducting trials. He has said that we did certain types of trials to speed things up. I don't mind the time the trials took or the fact that some were delayed by Covid. I do have a deep problem with the sitting on data. The full alz data should be out by now. Also the Rett excellence data should not take long, we have already done a Rett test and totalled the score before, so we know what we are looking for.
As for the magic 10 years, why cant we be better than average? This is our expertise after all.
And since it will take 6-12 months to get approval and start production to "get to market", we only have one year left, not two. I say we should be seeing actions (Rett data, NDA filing, alz data) this year.
8 years of "relaxing " without a shot on goal is enough.
Hey Kevin, I have been "sucking it up" since 2015.
canned answers on your part make one look like a blowhard
Another day of nothing.
Question for the patient longs: At what point do you get fed up with the glacial progress? What if we don't get the alz data in the 3rd quarter? What if there is no Rett NDA filed this year. What if there is no PD trial started this year? At what point does the lack of progress on milestones indicate deeper probelms?
Another week of nothing.
Get the Excellence top line data out.
Gt the NDA filed.
get the PD trial started
Get the full alz data out.
Bueller? Bueller?
Only with the filing of the NDA will we know for sure.
BEST POST: Maybe Blarcamesine in an aerosol form could be used to restore atmospheric homeostasis
LOL that's great!
This is what happens when AVLX sits on results instead of PRing them.
2 years now of stock declines...terrible
AVXL has lost 2/3 of it value.
Need as fast as possible:
1. top line Excellence data showing real improvement
2. NDA filed for fast track Rett approval
3. PD trial started
4. Full alz data release.
Dammit why cant they execute the plan?
Taurine - key ingredient to prevent alz and slow aging
Louzada, P. R. & Noe, O. I. S. Taurine prevents the neurotoxicity of ß-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disorders.
Does taurine slow aging?
Taurine Shown to Slow Aging in Animal Studies
Taurine, a nutrient found naturally in fish and meat and added as a supplement to many popular energy drinks, appears to help promote healthy aging — at least in mice and monkeys. Low taurine levels are associated with accelerated aging in many animal species, according to a new study published in Science.Jun 13, 2023
https://www.sciencedirect.com/science/article/abs/pii/B9780128158685000463#:~:text=It%20was%20reported%20that%20Alzheimer's,Brandi%20%26%20Tolosa%2C%201991).
Time to release top line Excellence data.
like NOW.
No mysteries on how to analyze this. Get it out.
I hope not: I THINK CTAD 2023 IN OCTOBER, the kraken will be released.
Let's quit worshipping conferences (and peer reviewed papers). Havent helped the stock one bit.
Get the full alz data processed, and release it yourself, in your own press conference where all the analysts are invited.
Release the Rett data, and give a hard date by when you will have the NDA filed.
Control your own destiny and timeline.
Absolutely not: Do you think the VC's who demanded a sale at $250M regret their decision not to wait another 5-10 years? I do.
VC funds live in the real world where investors expect a return on their investment after 5-10 years of waiting. They got the 15x return and correctly sold.
Right now AVXL investors have ZERO return after about 8 years.
If this stock was at $130 right now, I'd be happy to sell 25% of my holding and ride the rest to $1249 a share, but at friggin $8 the performance has been pizzzz poor. Time to get that NDA filed and return something to patient longs after 8 years of waiting.
Please provide the ticker please, so I can verify the story
NDAs, not peer reviewed articles
We're going for FDA approval, not tenure.
The solution is to get an NDA filed ASAP
Agree, peer reviewed paper is BS. We're not applying for tenure.
File the NDA in the 3rd quarter. Had enough tiime/
Get the Excellence top line data out and say you will file NDA in 3rd quarter.
Stock will double.
Like waiting for Godot: Waiting for strength and volume.
you would think the MM's would pump it up to $10 to lure in some more suck, er, investors, but instead the pressure is always down
SHOW ME THE MONEY!!!!!
weren't you going to go to the annual meeting and do just that?
The full alz data should come out sooner rather than later
Had it for over half a year now. Damaging the stock to not have it out.
Expect the AVXL share price to double, triple or quadruple within the next 3.5 weeks.
Hope so, needs to triple just to get back to 2021 levels, so much value has rotted away.
AVXL stock is a rock
always sinks, never gets above water
quotes were appropriate.
we need the real news of full alz results or NDA filing
AGAIN: again if they don't present at AAIC i believe due to the partnership deal we may have
Again Dr. M very clearly said no partnership until after 273 approved for alz.
please dont push stuff with no basis in fact. we have to speculate enough as is, so when we get a clear answer, accept it.
I dont think they will present at AAIC.
George was hyping AAIC, I replied it means nothing since no sign AVXL will present.
The AAIC starts in just 1 month
Where is AVXL's statement that they will present full alz data?
Without that AAIC means ZERO
raja sees clearly: Quad Witching today. Look out for High Volume settled at end of day.
Wow, 4 million. clearly a lot of fun and games going on.
If they are expecting a move up to $22 they must be expecting some very big news. Not holding my breath on that happening
at the minimum, it would have to be full alz data with unambiguous effectiveness including disease reversal
NO already: if they don't present at AAIC this year i believe we have a partnership deal.
Dr. M said clearly no partners until after approval to get best price. he says little clearly, but this was quite clear. So dont say otherwise.
NO: only corrupted FDA Keep on delaying AVXL
You have to play by filing the NDA to win.
No NDA, no play. Lets hope NDA filed by September.
"Yes. Rett seems like a lock for rapid approval wherever"--and when does "the market" believe this and price the stock accordingly ??????
When the full alz data is released or when the NDA is filed.
Alz or Rett. Get er done, Dr. M.
Special Access Program (SAP) applications are granted at a physicians’ request on behalf of patients. Based on the safety profile of ANAVEX®2-73 (blarcamesine), as well as clinical evidence that the study drug will continue to benefit patients
Still need to get the NDA's filed
Still need to release full alz data
Others are bricks, NDA is the Keystone
I don't see multiple patients making the request if they didn't see much benefit.
Even more so that the people making the request are not the patients, but their doctors.